BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 19261924)

  • 1. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.
    Al-Okaili RN; Krejza J; Woo JH; Wolf RL; O'Rourke DM; Judy KD; Poptani H; Melhem ER
    Radiology; 2007 May; 243(2):539-50. PubMed ID: 17456876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
    Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
    AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
    Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
    Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central nervous system involvement of leukemia and systemic lymphoma in children: CT and MR findings].
    Tomura N; Hirano H; Kato K; Sashi R; Hashimoto M; Watarai J; Watanabe A
    No To Shinkei; 1997 Nov; 49(11):993-1000. PubMed ID: 9396030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
    AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
    Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
    AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
    Thurnher SA
    AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
    Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
    AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.